Detalhe da pesquisa
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med;
389(6): 504-513, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37379158
2.
Radiological features characterising indeterminate testes masses: a systematic review and meta-analysis.
BJU Int;
131(3): 288-300, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35980855
3.
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
BMC Pulm Med;
23(1): 69, 2023 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809990
4.
Novel SLC12A2-ROS1 Fusion in Non-Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next-Generation Sequencing Assay.
Oncologist;
26(6): e908-e912, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33682977
5.
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.
Future Oncol;
17(30): 4011-4025, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34337973
6.
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
Br J Cancer;
123(5): 694-697, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32572174
7.
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Int J Mol Sci;
20(8)2019 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31027181
8.
Aligning digital CD8+ scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma.
Histopathology;
72(2): 270-284, 2018 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28815764
9.
Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
BMC Health Serv Res;
18(1): 147, 2018 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29490654
10.
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol;
18(12): 1652-1664, 2017 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29074099
11.
Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.
Future Oncol;
11(11): 1665-74, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26043218
12.
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.
Clin Transl Oncol;
26(2): 352-362, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37490262
13.
Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.
Sci Rep;
14(1): 11398, 2024 05 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762534
14.
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
Clin Transl Oncol;
26(7): 1647-1663, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38530556
15.
RET Fusion Testing in Patients With NSCLC: The RETING Study.
JTO Clin Res Rep;
5(4): 100653, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38525319
16.
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Clin Cancer Res;
2024 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38630755
17.
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Carcinogenesis;
34(5): 1031-8, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23349018
18.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol;
13(3): 239-46, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22285168
19.
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study.
Clin Transl Oncol;
25(1): 283-291, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36168085
20.
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Clin Transl Oncol;
25(5): 1252-1267, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36571695